<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1, aka PGP9.5) is an abundant, neuronal deubiquitinating enzyme that has also been suggested to possess E3 ubiquitin-protein ligase activity and/or stabilize ubiquitin monomers in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>Recent evidence implicates dysregulation of UCH-L1 in the pathogenesis and progression of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Although typically only expressed in neurons, high levels of UCH-L1 have been found in many nonneuronal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, including breast, colorectal, and pancreatic <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>UCH-L1 has also been implicated in the regulation of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and cell growth during the progression of nonsmall cell <z:mp ids='MP_0008714'>lung carcinoma</z:mp>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Together these studies suggest UCH-L1 has a potent oncogenic role and drives <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development </plain></SENT>
<SENT sid="5" pm="."><plain>Conversely, others have observed promoter methylation-mediated silencing of UCH-L1 in certain <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> subtypes, suggesting a potential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor role for UCH-L1 </plain></SENT>
<SENT sid="6" pm="."><plain>In this paper, we provide an overview of the evidence supporting the involvement of UCH-L1 in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development and discuss the potential mechanisms of action of UCH-L1 in <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> </plain></SENT>
</text></document>